Cancer and the microbiota
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
A host’s microbiota may increase, diminish, or have no effect at all on cancer susceptibility. Assigning causal roles in cancer to specific microbes and microbiotas, unraveling host-microbiota interactions with environmental factors in carcinogenesis, and exploiting such knowledge for cancer diagnosis and treatment are areas of intensive interest. This Review considers how microbes and the microbiota may amplify or mitigate carcinogenesis, responsiveness to cancer therapeutics, and cancer-associated complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Loss of microbial diversity (dysbiosis) is associated with chronic health conditions (26–28) and cancer (8–10), and is also associated with poor outcomes to certain forms of cancer therapy including allogeneic stem cell transplant (29).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“It has recently emerged that factors beyond tumor genomics influence cancer development and therapeutic responses (4–7), including host factors such as the gastrointestinal (gut) microbiome (8–10).”
From Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients (2018) · cites this paper as [8]
In the citing paper
“their gene count that exceeds the human genome’s gene count by ~100-fold and enables diverse metabolic programming”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“the number of microbes that inhabit the human body (roughly equal to the number of human cells)”
From The microbiome and human cancer (2021) · cites this paper as [31]
In the citing paper
“their effects on host immune system development and activity, including antitumor immunosurveillance (27–31).”
From The microbiome and human cancer (2021) · cites this paper as [31]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Self-citationMetabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Research works printed but not linked: 1
- 10.1111/j.1572-0241.2000.01860.x · doi:10.1111/j.1572-0241.2000.01860.x · Paper page
Cited by
Items 501–600 of 1,001
Gut microbial dysbiosis and its association with esophageal cancer
Ishaq, H. M., Mohammad, I. S., Muhammad, K. S., Li, H., Abbas, R. Z., Sindhu, Z. U. D., Ullah, S., Yang, F., Sadiq, A., Raza, M. A., et al. (2021) · Journal of Applied Biomedicine · doi:10.32725/jab.2021.005 · Cited by 30
“Garrett WS (2015). Cancer and the microbiota. Science 348: 80–86. DOI: 10.1126/science.aaa4972. Guarner F, Malagelada J-R (2003). Gut flora in health and disease. Lancet 361: 512–519. DOI: 10.1016/S0140-6736(03)12489-0. Hameed A, Ijaz S, Mohammad IS, Muhammad KS, Akhtar N, Khan HMS (2017). Aglycone solanidine and sola…”
BackgroundInfluentialChan, J. Y. K., Ng, C. W. K., Lan, L., Fung, S. Y. H., Li, J., Cai, L., Lei, P., Mou, Q., Meehan, K. L., Lau, E. H. L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.737843 · Cited by 31
miRNA as a Modulator of Immunotherapy and Immune Response in Melanoma
Nguyen, M.-H. T., Luo, Y.-H., Li, A.-L., Tsai, J.-C., Wu, K., Chung, P., & Ma, N. J.-L. (2021) · Biomolecules · doi:10.3390/biom11111648 · Cited by 33
Transmission of a common intestinal neoplasm in zebrafish by cohabitation
Burns, A. R., Watral, V. G., Sichel, S. R., Spagnoli, S., Banse, A. V., Mittge, E., Sharpton, T. J., Guillemin, K. J., & Kent, M. L. (2017) · Journal of Fish Diseases · doi:10.1111/jfd.12743 · Cited by 28
Meunier, A., Nerich, V., Fagnoni-Legat, C., Richard, M., Mazel, D., Adotévi, O., Bertrand, X., & Hocquet, D. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz070 · Cited by 34
Linking gut microbiota with human diseases
Vandana, U. K., Barlaskar, N. H., Gulzar, A. B. M., Laskar, I. H., Kumar, D., Paul, P., Pandey, P., & Mazumder, P. B. (2020) · Bioinformation · doi:10.6026/97320630016196 · Cited by 32
Vaginal Microbiome Dysbiosis is Associated with the Different Cervical Disease Status
Ma, Y., Li, Y., Liu, Y., Cao, L., Han, X., Gao, S., & Zhang, C. (2023) · The Journal of Microbiology · doi:10.1007/s12275-023-00039-3 · Cited by 92
“In addition, some bacteria were reported to produce compounds such as colibactin and cytolethal distending toxins that can induce DNA damage and/or cell proliferation, and facilitate cancer development (Curty et al., 2019; Garrett, 2015; Schwabe & Jobin, 2013).”
BackgroundInfluentialRecent advances and future perspectives of CAR-T cell therapy in head and neck cancer
Hu, C., Liu, M., Li, Y., Zhao, Y., Sharma, A., Liu, H., & Schmidt‐Wolf, I. G. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1213716 · Cited by 36
“suggest cancer exome-based identification of neoantigens for each patient and assess T cell recognition before generating CAR-T cells (36).”
BackgroundLiu, Y., Kim, E. S., & Guo, H. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29485 · Cited by 31
Cancer invasion and anaerobic bacteria: new insights into mechanisms
Hurst, R., Brewer, D. S., Gihawi, A., Wain, J. R., & Cooper, C. S. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001817 · Cited by 29
“Host changes include increased gene expression of NFK β , IL8, IL6 and Wnt, alteration in oncogenes Myc and Cyclin D1, and Rac1 and Cyclin D1 activation, overall causing increased growth stimulation of the host cell and facilitating bacteria uptake [6, 44, 45].”
InfluentialSystematic evaluation of immune regulation and modulation
Stroncek, D. F., Butterfield, L. H., Cannarile, M. A., Dhodapkar, M. V., Greten, T. F., Grivel, J., Kaufman, D. R., Kong, H. H., Korangy, F., Lee, P. P., et al. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0223-8 · Cited by 32
Untersmayr, E., Bax, H. J., Bergmann, C., Bianchini, R., Cozen, W., Gould, H. J., Hartmann, K., Josephs, D. H., Levi‐Schaffer, F., Penichet, M. L., et al. (2019) · Allergy · doi:10.1111/all.13718 · Cited by 27
“NDO protect against allergic manifestations in experimental models of food allergy and allergic asthma43,44 and reshape the gut microbiota with increased levels of short‐chain fatty acids (SCFAs).45 Less is known concerning the anti‐cancer effects of NDO.46 Experimental models show encouraging effects of GOS, FOS, aga…”
BackgroundHogue, S., Gómez, M. F. L., da Silva, W. V., & Pierce, C. M. (2019) · Microbial Ecology · doi:10.1007/s00248-019-01346-2 · Cited by 27
Colov, E. P., Degett, T. H., Raskov, H., & Gögenür, I. (2020) · Apmis · doi:10.1111/apm.13032 · Cited by 31
“cause direct DNA damage aiding the development of cancer cells (1, 6, 7, 10).”
BackgroundThe potential role of bacteria in pancreatic cancer: a systematic review
Li, P., Shu, Y., & Gu, Y. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa013 · Cited by 34
The fluidity of biosocial identity and the effects of place, space, and time
Wiese, D., Escobar, J. R., Hsu, Y., Kulathinal, R. J., & Conroy, A. H. (2017) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.12.023 · Cited by 32
Spatial Heterogeneity of Intratumoral Microbiota: A New Frontier in Cancer Immunotherapy Resistance
Tan, Q., Cao, X., Zou, F., Wang, H., Xiong, L., & Deng, S. (2025) · Biomedicines · doi:10.3390/biomedicines13051261 · Cited by 35
“Intratumoral microbiota interact with host cells and the tumor microenvironment (TME), thereby influencing tumor initiation, progression, and therapeutic responses [10].”
Goc, J., Hepworth, M. R., & Sonnenberg, G. F. (2015) · International Immunology · doi:10.1093/intimm/dxv056 · Cited by 29
The therapeutic potential of metformin in gastric cancer
Courtois, S., Lehours, P., & Bessède, E. (2019) · Gastric Cancer · doi:10.1007/s10120-019-00952-w · Cited by 28
“Hence, as it is known that microbiota can influence cancer development and progression [60], future studies could be performed to eventually demonstrate whether metformin has indirect antitumour properties via its effects on microbiota.”
BackgroundThe Clinical Relevance of the Microbiome in Hidradenitis Suppurativa: A Systematic Review
Mintoff, D., Borg, I., & Pace, N. P. (2021) · Vaccines · doi:10.3390/vaccines9101076 · Cited by 32
Gut Microbiota: A Potential Target for Cancer Interventions
Zhou, H., Yuan, Y., Wang, H., Xiang, W., Li, S., Zheng, H., Wen, Y., Yang, M., Chen, L., & Zhou, J. (2021) · Cancer Management and Research · doi:10.2147/cmar.s328249 · Cited by 30
“responsiveness to cancer treatments, and cancer-related complications.(7) Helmink et al mainly reviewed the effects”
BackgroundRedrawing therapeutic boundaries: microbiota and cancer
Sholl, J., Sepich‐Poore, G. D., Knight, R. D., & Pradeu, T. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.10.008 · Cited by 33
Hawkins, G. M., Burkett, W. C., McCoy, A. N., Nichols, H. B., Olshan, A. F., Broaddus, R. R., Merker, J. D., Weissman, B. E., Brewster, W. R., Roach, J. M., et al. (2022) · Gynecologic Oncology · doi:10.1016/j.ygyno.2022.02.021 · Cited by 30
Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy
Zhou, P., Hu, Y., Wang, X., Shen, L., Liao, X., Zhu, Y., Yu, J., Zhao, F., Zhou, Y., Shen, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.877939 · Cited by 31
“It is worth noting that the relationship between microorganisms and cancer is complex, and there is also an intricate network of factors causing tumor immunotherapy effect by microorganisms (13).”
BackgroundKim, S., Kim, Y., Lee, S., Kim, Y., Jeon, B., Kim, H., & Park, H. (2022) · Cancers · doi:10.3390/cancers14174083 · Cited by 30
“The gut microbiota is a key factor in the response to cancer therapy, since many studies have implied that gut dysbiosis contributes to carcinogenesis [58,59] and drug responsiveness [17,60].”
BackgroundZhou, B., Dong, C., Zhao, B., Lin, K., Tian, Y., Zhang, R., Zhu, L., Xu, H., & Yang, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1015130 · Cited by 29
“The gut microbiota is closely related to the development of cancers and autoimmune diseases (Kamada et al., 2013; Garrett, 2015; Zitvogel et al., 2017; Yachida et al., 2019).”
BackgroundBourbonne, V., Schick, U., Pradier, O., Visvikis, D., Metges, J., & Badic, B. (2023) · Cancers · doi:10.3390/cancers15020432 · Cited by 27
Molecular principles of tissue invasion and metastasis
Dhanisha, S. S., & Guruvayoorappan, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00348.2022 · Cited by 31
Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response
Chai, Y., Huang, Z., Shen, X., Lin, T., Zhang, Y., Xu, F., Mao, Q., & Liang, Y. (2023) · Microorganisms · doi:10.3390/microorganisms11051240 · Cited by 29
Intratumoural microbiota: from theory to clinical application
Ji, H., Jiang, Z., Wei, C., Ma, Y., Zhao, J., Wang, F., Zhao, B., Wang, D., & Tang, D. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01134-z · Cited by 29
“causes NK and T cell inactivation [9] [17]”
BackgroundInfluentialModel Colibactins Exhibit Human Cell Genotoxicity in the Absence of Host Bacteria
Shine, E. E., Xue, M., Patel, J. R., Healy, A. R., Surovtseva, Y. V., Herzon, S. B., & Crawford, J. M. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00714 · Cited by 27
Silveira, A. K., Moresco, K. S., Gomes, H. M., Morrone, M. D. S., Grün, L. K., Gelain, D. P., Pereira, L. D. M., Giongo, A., de Oliveira, R. R., & Moreira, J. C. F. (2018) · Phytotherapy Research · doi:10.1002/ptr.6185 · Cited by 35
Wurm, P., Dörner, E., Kremer, C., Spranger, J., Maddox, C., Halwachs, B., Harrison, U., Blanchard, T. G., Haas, R., Högenauer, C., et al. (2018) · mSystems · doi:10.1128/msystems.00262-18 · Cited by 34
Duttagupta, S., Hakozaki, T., Routy, B., & Messaoudene, M. (2023) · Current Oncology · doi:10.3390/curroncol30110681 · Cited by 31
“Approximately 20% of human malignancies are attributed to specific individual microbes including H. pylori , hepatitis B and C, and human papillomavirus, causing gastric, liver, and cervical and uterine cancers [17,18].”
BackgroundLou, J., Cui, S., Li, J., Jin, G., Fan, Y., & Huang, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1279680 · Cited by 32
“Numerous microbiological studies have gradually con fi rmed the relationship between intestinal fl ora imbalance and the occurrence of type-2 diabetes (4), obesity (5), fatty liver (6), atherosclerosis (7), cancer (8), and other chronic diseases (9).”
BackgroundMetabolomics in the era of artificial intelligence
Coler, E., Chen, W., Melnik, A. V., Morton, J. T., & Aksenov, A. A. (2024) · Microbiota and Host · doi:10.1530/mah-23-0017 · Cited by 35
Tezé, D., Shuoker, B., Chaberski, E. K., Kunstmann, S., Fredslund, F., Nielsen, T. S., Stender, E. G. P., Peters, G. H. J., Karlsson, E. N., Welner, D. H., et al. (2020) · ACS Catalysis · doi:10.1021/acscatal.9b04474 · Cited by 25
Microbiome-based interventions: therapeutic strategies in cancer immunotherapy
Chervin, C. S., & Gajewski, T. F. (2020) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2020.11.001 · Cited by 29
Addressing Resistance to Immune Checkpoint Inhibitor Therapy: An Urgent Unmet Need
Hu‐Lieskovan, S., Malouf, G. G., Jacobs, I. A., Chou, J., Liu, L., & Johnson, M. L. (2021) · Future Oncology · doi:10.2217/fon-2020-0967 · Cited by 31
Läsche, M., Urban, H., Gallwas, J. K. S., & Gründker, C. (2021) · Cells · doi:10.3390/cells10030714 · Cited by 28
“In case of a persistent infection and the negative effects of an accompanying pathological microbiota [2], the immune system will no longer be able to completely control and eliminate the viral disease [120,121].”
BackgroundInfluentialShen, X., Zhang, B., Hu, X., Li, J., Wu, M., Yan, C., Yang, Y., & Li, Y. (2022) · Bioengineered · doi:10.1080/21655979.2022.2078556 · Cited by 34
“DNA damage signaling can be detected by modification of the phosphorylation of histone H2A variant (H2AX), ataxia-telangiectasiamutated-and Rad3-related (ATR) and checkpoint kinase1 (CHK1), to maintain genome stability [12].”
InfluentialRetractedThe role of microbiota in the development and treatment of gastric cancer
Wang, Y., Han, W., Wang, N., Han, M., Ban, M., Dai, J., Dong, Y., Sun, T., & Xu, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1224669 · Cited by 30
“Gastric cancer is the result of the interaction between the dysbiosis of the gastric microbiota and the host gastric epithelial cells (6).”
BackgroundEmerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies
Shi, Z., Li, Z., & Zhang, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05640-7 · Cited by 27
“Additionally, cytokines such as IL-6 and TNF-α, stimulated by intratumor microbiota, could activate the NF-κB and STAT3 signaling and facilitate tumor proliferation [112].”
BackgroundAdvancements in Biomarkers of Prostate Cancer: A Review
Agbetuyi-Tayo, P. T., Gbadebo, M., Rotimi, O. A., & Rotimi, S. O. (2024) · Technology in Cancer Research & Treatment · doi:10.1177/15330338241290029 · Cited by 25
“120,121 In 2018, Golombos et al observed a signi fi cant prevalence of Bacteroides massiliensis in the GM of PCa patients while observing a similarity in the diversity of GM in PCa patients and healthy controls.”
BackgroundEpigenetic Treatment of Persistent Viral Infections
Moos, W. H., Pinkert, C. A., Irwin, M. H., Faller, D. V., Kodukula, K., Glavas, I. P., & Steliou, K. (2016) · Drug Development Research · doi:10.1002/ddr.21366 · Cited by 25
Precision medicine ― A promising, yet challenging road lies ahead
Malod‐Dognin, N., Petschnigg, J., & Pržulj, N. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.10.003 · Cited by 29
Kobæk-Larsen, M., Nielsen, D. S., Kot, W., Krych, Ł., Christensen, L. P., & Baatrup, G. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3527-y · Cited by 25
Potential Use of Biotherapeutic Bacteria to Target Colorectal Cancer-Associated Taxa
Lawrence, G. W., Begley, M., Cotter, P. D., & Guinane, C. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030924 · Cited by 25
Perry, L. M., Cruz, S. M., Kleber, K. T., Judge, S. J., Darrow, M. A., Jones, L. B., Basmaci, U. N., Joshi, N., Settles, M. L., Durbin-Johnson, B. P., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004285 · Cited by 30
Nutrition in cancer patients with cachexia: A role for the gut microbiota?
Bindels, L. B., & Thissen, J.-P. (2015) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2015.11.001 · Cited by 27
The diet-microbiota-metabolite axis regulates the host physiology
Yamada, T., Takahashi, D., & Hase, K. (2016) · The Journal of Biochemistry · doi:10.1093/jb/mvw022 · Cited by 30
HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases
Herrera, S., Martínez‐Sanz, J., & Villar, S. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01466 · Cited by 29
“Beyond the neoplasias directly linked to infectious agents, increasing evidence reveals that microbial communities as a whole play a key role in carcinogenesis by altering the balance of host cell proliferation and apoptosis; hindering anti-tumoral immunity; and influencing the metabolism of host-produced factors, ing…”
BackgroundNovel Forms of Immunomodulation for Cancer Therapy
del Valle, A. S., Naval, J., Anel, A., & Marzo, I. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.02.015 · Cited by 26
Gao, J., Tang, L., Fu, C., Cao, Y., Liu, H., Yin, Y., Li, Z., Zhu, Y., Shu, W., Zhang, Y., et al. (2025) · Nano Letters · doi:10.1021/acs.nanolett.5c00298 · Cited by 29
Bacteriophages Synergize with the Gut Microbial Community To Combat Salmonella
Hu, Y. O. O., Hugerth, L. W., Bengtsson, C., Alisjahbana, A., Seifert, M., Kamal, A., Sjöling, Å., Midtvedt, T., Norin, E. L., Du, J., et al. (2018) · mSystems · doi:10.1128/msystems.00119-18 · Cited by 27
Immunotherapy in head and neck cancer: The great challenge of patient selection
Napolitano, M., Schipilliti, F. M., Trudu, L., & Bertolini, F. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.102829 · Cited by 24
Cancer Genomics in Precision Oncology: Applications, Challenges, and Prospects
Pereira, M. A., Kunrath‐Lima, M., Couto, P. G. P., Penna, M. G., Alvim, L. B., Nani, T. F., Freire, M. C. M., & Araujo, L. H. (2020) · Springer eBooks · doi:10.1007/978-981-15-1067-0_21 · Cited by 47
A Role for MAIT Cells in Colorectal Cancer
Berzins, S. P., Wallace, M. E., Kannourakis, G., & Kelly, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00949 · Cited by 30
“The counter argument is that chronic exposure to pro-inflammatory cytokines such as TNF and especially IL-17, can promote a tumorigenic microenvironment that is immunosuppressive (29, 32, 46).”
BackgroundThe discovery of bacterial biofilm in patients with muscle invasive bladder cancer
Nadler, N., Kvich, L., Bjarnsholt, T., Jensen, J. B., Gögenür, I., & Azawi, N. (2020) · Apmis · doi:10.1111/apm.13097 · Cited by 23
“DNA damage by the covalent binding of DNA to a chemical moiety that is known to promote tumorigenesis (6).”
BackgroundDietary intervention as a therapeutic for cancer
Morita, M., Kudo, K., Shima, H., & Tanuma, N. (2020) · Cancer Science · doi:10.1111/cas.14777 · Cited by 28
Upper Gastrointestinal Cancer and Liver Cirrhosis
Jeng, K., Chang, C., Sheen, I., Jeng, C., & Wang, C.-H. (2022) · Cancers · doi:10.3390/cancers14092269 · Cited by 26
“It has been hypothesized that gut dysbiosis could trigger the development of some types of cancer via systemic mechanisms, including metabolic changes to affect precancerous cells and immune cells [88,89].”
BackgroundIntratumor microbiota: a novel tumor component
Gong, Y., Huang, X., Wang, M., & Liang, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04576-7 · Cited by 28
“2017; Garrett 2015; Shalapour and Karin 2020).”
BackgroundHatcher, C., Richenberg, G., Waterson, S., Nguyen, L. H., Joshi, A. D., Carreras‐Torres, R., Moreno, V. R., Chan, A. T., Gunter, M. J., Lin, Y., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-31840-0 · Cited by 29
How Can the Microbiome Induce Carcinogenesis and Modulate Drug Resistance in Cancer Therapy?
Mendes, I., & Vale, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411855 · Cited by 24
Oral Microbiota: A New Insight into Cancer Progression, Diagnosis and Treatment
Wang, X., Xu, H.-W., & Liu, N. (2023) · Phenomics · doi:10.1007/s43657-023-00124-y · Cited by 29
“…contributing to carcinogenesis and modulation of cancers pathogenesis such as host genetic regulation, oral microbiota metabolic activities and modulation of cancer pathogenesis, including cell cycle regulation, cell proliferation and cell apoptosis (Milella 2015; Garrett 2015; Karpiński 2019).”
BackgroundTian, J., Xue, W., Yin, H., Zhang, N., Zhou, J., Long, Z., Wu, C., Liang, Z., Xie, K., Li, S., et al. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s247393 · Cited by 24
Systems to model the personalized aspects of microbiome health and gut dysbiosis
Matthewman, C., Narin, A., Huston, H., & Hopkins, C. E. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101115 · Cited by 23
The intratumoral microbiota: a new horizon in cancer immunology
Liu, W., Li, Y., Wu, P., Guo, X., Xu, Y., Jin, L., & Zhao, D. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1409464 · Cited by 24
“Several primary modes of interaction may exist between the intratumoral microbiota and developing cancer (Garrett, 2015): (1) promotion of tumorigenesis via increases in host genomic instability and mutations, such as the DNA damage induced by the colibactin toxin of polyketide synthase (pks)+…”
BackgroundInfluentialGut microbiota as a hidden modulator of chemotherapy: implications for colorectal cancer treatment
Sadeghloo, Z., & Sadeghi, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-03574-0 · Cited by 27
“Evidence confirms that alterations in the gut microbiota composition and function—a condition known as dysbiosis—are closely associated with CRC pathogenesis and regulation of therapeutic responses [5, 6].”
3-D Microwell Array System for Culturing Virus Infected Tumor Cells
Assal, R. E., Gurkan, U. A., Chen, P., Juillard, F., Tocchio, A., Chinnasamy, T., Beauchemin, C., Unluisler, S., Canikyan, S., Holman, A. R., et al. (2016) · Scientific Reports · doi:10.1038/srep39144 · Cited by 25
Pensec, C., Gillaizeau, F., Guénot, D., Bessard, A., Carton, T., Leuillet, S., Campone, M., Neunlist, M., Blottière, H. M., & Vacon, F. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-65792-6 · Cited by 24
Screening for prevalence and abundance of Capnocytophaga spp by analyzing NGS data: A scoping review
Jolivet‐Gougeon, A., & Bonnaure‐Mallet, M. (2020) · Oral Diseases · doi:10.1111/odi.13573 · Cited by 23
“Indeed, microbial metabolites can contribute to inflammatory process and influence the balance of proliferation and cell death in tissues (Garrett, 2015, Perera et al., 2018, Vergara, 2019).”
BackgroundEffect of Streptococcus anginosus on biological response of tongue squamous cell carcinoma cells
Xu, Y., Jia, Y., Chen, L., Gao, J., & Yang, D. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01505-3 · Cited by 21
Scavizzi, F., Bassi, C., Lupini, L., Guerriero, P., Raspa, M., & Sabbioni, S. (2021) · Animal Microbiome · doi:10.1186/s42523-021-00113-4 · Cited by 22
Hou, K., Wu, Z., Chen, Y., Zhu, D., Zheng, Y., & Ali, K. B. (2021) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892816666210929164930 · Cited by 24
Rye, M. S., Garrett, K. L., Holt, R. A., Platell, C. F. E., & McCoy, M. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262416 · Cited by 25
Immunomodulation by Gut Microbiome on Gastrointestinal Cancers: Focusing on Colorectal Cancer
AL-Ishaq, R. K., Koklesová, L., Kubatka, P., & Büsselberg, D. (2022) · Cancers · doi:10.3390/cancers14092140 · Cited by 24
Gupta, I., Pedersen, S., Vranić, S., & Moustafa, A. A. (2022) · Cancers · doi:10.3390/cancers14122964 · Cited by 26
Yan, J., Zheng, D., Gu, H.-Y., Yu, Y., Zeng, J., Chen, Q., Yu, A., & Zhang, X. (2022) · Advanced Science · doi:10.1002/advs.202205480 · Cited by 26
Li, Y., Zhang, D., Wang, M., Jiang, H., Feng, C., & Li, Y. (2023) · iMeta · doi:10.1002/imt2.102 · Cited by 22
“DNA damage caused by the microbiota further increases host genetic mutations, which may finally cause tumorigenesis [45].”
BackgroundModifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
Michalak, N., & Małecka-Wojciesko, E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134318 · Cited by 35
“The data are accumulating on the role of microbial dysbiosis in oncogenesis [95].”
BackgroundThe evil companion of OSCC : Candida albicans
Yang, Z., Zhang, S., Ji, N., Li, J., & Chen, Q. (2023) · Oral Diseases · doi:10.1111/odi.14700 · Cited by 27
Huang, J., Gong, C., & Zhou, A. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231204854 · Cited by 33
“The intratumoral microbiome constitutes a significant part of TME, influencing tumorigenesis, progression, metastasis, and antitumor immunity, 152 especially the extent of immune infiltration and the degree of activation of CD8 + T cells, 153–156 which are important factors affecting ICI efficacy.”
BackgroundUnveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy
Zhang, J., Wang, P., Wang, J., Wei, X., & Wang, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107185 · Cited by 26
Kazemi-Sefat, N. A., Mohammadi, M. M., Hadjati, J., Talebi, S., Ajami, M., & Daneshvar, H. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1595643 · Cited by 24
Assessment of oncogenic role of intestinal microbiota in colorectal cancer patients
D’asheesh, T. A., Hussen, B. M., AL-Marzoqi, A. H., & Ghasemian, A. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00531-8 · Cited by 25
Untangling the web of intratumor microbiota in lung cancer
Liu, W. L., Xu, J., Pi, Z., Chen, Y., Jiang, G., Wan, Y., & Mao, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189025 · Cited by 31
Vaginal microbiota and gynecological cancers: a complex and evolving relationship
Javadi, K., Ferdosi-Shahandashti, E., Rajabnia, M., & Khaledi, M. (2024) · Infectious Agents and Cancer · doi:10.1186/s13027-024-00590-7 · Cited by 27
Kulecka, M., Czarnowski, P., Bałabas, A., Turkot, M. H., Kruczkowska‐Tarantowicz, K., Żeber‐Lubecka, N., Dąbrowska, M., Paszkiewicz‐Kozik, E., Walewski, J. A., Lugowska, I. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158026 · Cited by 27
“…as Fusobacterium nucleatum , Escherichia coli , Bacteroides fragilis , Aspergillus , Clostridium septicum , Enterococcus faecalis , and Streptococcus bovis are known to drive colorectal carcinogenesis [20,21,24], most species associated with CRC are observed in only a minority of datasets [1,2].”
BackgroundXu, H., Leng, J., Liu, F., Chen, T., Qu, J., Yang, Y., Ning, C., Ke, X., Xiao, B., Zhang, Y., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38310 · Cited by 24
Application of photosensitive microalgae in targeted tumor therapy
Wang, R., Wang, Z., Zhang, M., Zhong, D., & Zhou, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115519 · Cited by 27
Crosstalk between gut microbiota and RNA N6-methyladenosine modification in cancer
Su, H., Cheung, H., Lau, H. C.-H., Chen, H., Zhang, X., Wang, Y., Wang, Y., Chan, M. T. V., Wu, W. K. K., & Chen, H. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad036 · Cited by 25
Current advances in bacteria‐based cancer immunotherapy
Guo, C., Liu, J., & Zhang, Y. (2023) · European Journal of Immunology · doi:10.1002/eji.202350778 · Cited by 23
“Once bacteria with synchronous lysis circuits reach a certain threshold within the tumor, they activate the circuits, leading to self-lysis and the release of loaded material [41].”
BackgroundAiding and Abetting: How the Tumor Microenvironment Protects Cancer from Chemotherapy
Fiedler, E. C., & Hemann, M. T. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055524 · Cited by 25
“Additional microbial proteins, including certain virulence factors, can engage host pathways that are important in carcinogenesis and inflammation (Garrett 2015).”
BackgroundImmunogenic cell death: A link between gut microbiota and anticancer effects
Chen, W., Wang, S., Wu, Y., Shen, X., Guo, Z., Li, Q., & Xing, D. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.103983 · Cited by 22
Park, R., Umar, S., & Kasi, A. (2020) · Current Colorectal Cancer Reports · doi:10.1007/s11888-020-00456-1 · Cited by 28
Cell-Nonautonomous Mechanisms Underlying Cellular and Organismal Aging
Medkour, Y., Svistkova, V., & Titorenko, V. I. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.09.003 · Cited by 26
Hu, M., Du, Y., Li, W., Zong, X., Du, W., Sun, H., Liu, H., Zhao, K., Li, J., Farooq, M. Z., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202400251 · Cited by 25
Relationships between bacteria and the mucus layer
Brockhausen, I., Falconer, D., & Sara, S. (2024) · Carbohydrate Research · doi:10.1016/j.carres.2024.109309 · Cited by 22
Interactions between the tumor microbiota and breast cancer
Guo, H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1499203 · Cited by 29
Metadata
- Authors
- Garrett, W. S.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Garrett, Wendy S.
- ORCID
- Garrett, Wendy S.
- Venue
- Science
- Published
- 2015-04-03
- Volume
- 348
- Issue
- 6230
- Pages
- 80-86
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5535753
- OpenAlex
- W2073924079
- Cited by
- 1,404
- References
- 119
- Citations by year
- 2026: 145 · 2025: 169 · 2024: 169 · 2023: 151 · 2022: 162 · 2021: 141 · 2020: 127 · 2019: 106 · 2018: 77 · 2017: 68 · 2016: 58 · 2015: 29
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01CA154426)
- Burroughs Wellcome Career in Medical Sciences Award
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Keywords
- gut microbiota, cancer susceptibility, carcinogenesis, host-microbe interactions, cancer therapy response, cancer diagnosis
- MeSH terms
- Humans, Immunotherapy, Neoplasms, Carcinogenesis, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.